⌘K

Home/Filings/4/0001209191-23-013229

4//SEC Filing

Friedman Bart 4

Accession 0001209191-23-013229

CIK 0001636651other

View on SEC.gov Company Profile

Filed

Feb 26, 7:00 PM ET

Accepted

Feb 27, 4:55 PM ET

Size

5.3 KB

Accession

0001209191-23-013229

Insider Transaction Report

Form 4

Period: 2023-02-23

Ovid Therapeutics Inc.OVID

Director

Transactions

Award
Stock Option (Right to Buy)
2023-02-23+15,000→ 15,000 total
Exercise: $2.50Exp: 2033-02-22→ Common Stock (15,000 underlying)

Footnotes (1)

[F1]The option will vest in full on February 23, 2024 subject to the Reporting Person's continuous service through such vesting date.

Documents

1 file

4
doc4.xmlPrimary
FORM 4 SUBMISSION

Issuer

Ovid Therapeutics Inc.

CIK 0001636651

Entity typeother

Related Parties

1

filerCIK 0001368324

Filing Metadata

Form type: 4
Filed: Feb 26, 7:00 PM ET
Accepted: Feb 27, 4:55 PM ET
Size: 5.3 KB

View on SEC.gov